Neuralink will begin human trials in Canada, NYTimes says OpenAI deleted evidence in its copyright lawsuit, and Chemists have created the world's thinnest spaghetti

Neuralink gets approval to start human trials in Canada, The New York Times says OpenAI deleted evidence in its copyright lawsuit, and Chemists have created the world's thinnest spaghetti. It has a medical use. It's Thursday, November 22nd and this is Engadget News. Learn more about your ad choices. Visit podcastchoices.com/adchoices